Application 202308
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AZITHROMYCIN | AZITHROMYCIN | SOLUTION; OPHTHALMIC | 1% | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AZITHROMYCIN | AZITHROMYCIN | DirectRx | d564d91e-3039-c120-e053-2995a90ae6db | 2025-01-21 | Warnings, Adverse reactions | AZITHROMYCIN AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Zydus Lifesciences Limited | 0b63649d-558c-4250-90ee-af6e1e5c6d2c | 2025-01-09 | Azithromycin AZITHROMYCIN | |
| Azithromycin | AZITHROMYCIN | Advanced Rx Pharmacy of Tennessee, LLC | f175496a-4ad3-ce0d-e053-2a95a90a6613 | 2024-12-31 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Fresenius Kabi USA, LLC | b69917c0-95d5-4b29-b0e3-07054a4fd79f | 2024-10-11 | Warnings, Adverse reactions | Azithromycin |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Fresenius Kabi USA, LLC | 9ad099d5-5c57-4855-98a4-e03fb4629dbf | 2024-10-11 | Warnings, Adverse reactions | Azithromycin |
| Azithromycin | AZITHROMYCIN | Asclemed USA, Inc. | 22a4d2b3-daea-4d96-891f-4b9823629456 | 2024-10-04 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Proficient Rx LP | 90605f94-93e1-43d1-8be7-830e816ac84f | 2024-10-01 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Proficient Rx LP | 38942011-f86b-4e42-a4ca-05a70d9dd3d9 | 2024-10-01 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | Sagent Pharmaceuticals | 6497fb5e-82d8-4411-b994-7ee01333ffd7 | 2024-09-19 | Warnings, Adverse reactions | Azithromycin |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | f97d2e7e-ccfd-4f04-85ba-549b37f6aa7b | 2024-07-22 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | b0138503-ddc4-2e1c-e053-2995a90a0d2d | 2024-07-17 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | b43d23c7-1a2e-ce93-e053-2995a90a65a4 | 2024-07-17 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 549cdd0a-da79-23b8-e054-00144ff8d46c | 2024-07-17 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| AZITHROMYCIN | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 90a506cd-aae7-a622-e053-2a95a90ad352 | 2024-06-19 | Warnings, Adverse reactions | AZITHROMYCIN AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 9270e676-3382-6483-e053-2a95a90a556e | 2024-06-19 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 8e7184e1-3c3c-cd87-e053-2a95a90a6eb6 | 2024-06-18 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| AZITHROMYCIN | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 82454fb2-e524-ecb8-e053-2991aa0a6e7c | 2024-06-14 | Warnings, Adverse reactions | AZITHROMYCIN AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 826f9c07-8eb9-a128-e053-2991aa0ad654 | 2024-06-14 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| AZITHROMYCIN | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 8389c336-25eb-a96f-e053-2a91aa0a0dd8 | 2024-06-14 | Warnings, Adverse reactions | AZITHROMYCIN AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | 896cce83-23ac-f4ed-e053-2a95a90ad107 | 2024-06-14 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 10019 | ORIG | 2014-02-26 |